Literature DB >> 18716555

Elevated matrix metalloproteinase-9 and degradation of perineuronal nets in cerebrocortical multiple sclerosis plaques.

Elizabeth Gray1, Taya Louise Thomas, Samar Betmouni, Neil Scolding, Seth Love.   

Abstract

Matrix metalloproteinases (MMPs) degrade extracellular matrix; MMP activity, particularly of MMP-9, is elevated in the white matter in multiple sclerosis (MS) patients. The cerebral cortical extracellular matrix includes perineuronal nets (PNs) that surround parvalbumin-positive neurons (PV-positive neurons) and are important for their function. We measured active and total MMP-9 levels in postmortem homogenates of demyelinated and nondemyelinated cerebral cortical regions from 9MS and 7 control cases and assessed Wisteria floribunda agglutin (WFA)-positive PNs in paraffin sections from 15 MS and 6 controls and PV-positive neurons in sections from 26 MS and 6 controls. Active MMP-9 levels were higher in demyelinated than in nondemyelinated or control cortex (p < 0.05). The area fraction positive for WFA was lower in demyelinated than nondemyelinated MS or control cortex; the latter difference was significant (p < 0.05). Most PV-positive neurons in demyelinated but not intact cortex lackeda PN, and some showed perikaryal phosphorylated neurofilament protein accumulation. Loss of WFA-labeled PNs was not associated with reduced PV-positive neurons numbers. Thus, elevated MMP-9 in cortical plaques is associated with loss of PNs; PV-positive neurons are preserved but show abnormal neurofilament accumulations. Matrix metalloproteinase-mediated degradation of PNs in cortical plaques may, therefore, contribute to neuronal dysfunction and degeneration in MS patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716555     DOI: 10.1097/NEN.0b013e318183d003

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  14 in total

Review 1.  Pathophysiology of the brain extracellular matrix: a new target for remyelination.

Authors:  Lorraine W Lau; Rowena Cua; Michael B Keough; Sarah Haylock-Jacobs; V Wee Yong
Journal:  Nat Rev Neurosci       Date:  2013-08-29       Impact factor: 34.870

Review 2.  Losing the sugar coating: potential impact of perineuronal net abnormalities on interneurons in schizophrenia.

Authors:  Sabina Berretta; Harry Pantazopoulos; Matej Markota; Christopher Brown; Eleni T Batzianouli
Journal:  Schizophr Res       Date:  2015-01-16       Impact factor: 4.939

3.  Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases.

Authors:  Manishabrata Bhowmick; Dorota Tokmina-Roszyk; Lillian Onwuha-Ekpete; Kelli Harmon; Trista Robichaud; Rita Fuerst; Roma Stawikowska; Bjorn Steffensen; William Roush; Hector R Wong; Gregg B Fields
Journal:  J Med Chem       Date:  2017-04-19       Impact factor: 7.446

Review 4.  Points of divergence on a bumpy road: early development of brain and immune threat processing systems following postnatal adversity.

Authors:  Heather C Brenhouse
Journal:  Mol Psychiatry       Date:  2022-06-15       Impact factor: 13.437

5.  Editorial: Perineuronal Nets as Therapeutic Targets for the Treatment of Neuropsychiatric Disorders.

Authors:  Caroline A Browne; Katherine Conant; Amy W Lasek; Juan Nacher
Journal:  Front Synaptic Neurosci       Date:  2022-06-10

Review 6.  A further TWEAK to multiple sclerosis pathophysiology.

Authors:  Arash Nazeri; Pouria Heydarpour; Shokufeh Sadaghiani; Mohammad Ali Sahraian; Linda C Burkly; Amit Bar-Or
Journal:  Mol Neurobiol       Date:  2013-07-20       Impact factor: 5.590

Review 7.  Weaving a Net of Neurobiological Mechanisms in Schizophrenia and Unraveling the Underlying Pathophysiology.

Authors:  Byron K Y Bitanihirwe; Sarah A Mauney; Tsung-Ung W Woo
Journal:  Biol Psychiatry       Date:  2016-03-09       Impact factor: 13.382

Review 8.  Perineuronal nets and schizophrenia: the importance of neuronal coatings.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2014-04-04       Impact factor: 8.989

9.  Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes.

Authors:  Nellie A Martin; Arkadiusz Nawrocki; Viktor Molnar; Maria L Elkjaer; Eva K Thygesen; Miklos Palkovits; Peter Acs; Tobias Sejbaek; Helle H Nielsen; Zoltan Hegedus; Finn Sellebjerg; Tihamer Molnar; Eudes G V Barbosa; Nicolas Alcaraz; Ferenc Gallyas; Asa F Svenningsen; Jan Baumbach; Hans Lassmann; Martin R Larsen; Zsolt Illes
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

10.  Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis.

Authors:  Liam E Potter; John W Paylor; Jee Su Suh; Gustavo Tenorio; Jayalakshmi Caliaperumal; Fred Colbourne; Glen Baker; Ian Winship; Bradley J Kerr
Journal:  J Neuroinflammation       Date:  2016-06-10       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.